# Single Dose Administration of Alpha-1 Anti-Trypsin for the Amelioration of Organ Injury in Patients Undergoing Cardiac Surgery

> **NCT02191839** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Soroka University Medical Center** · enrollment: 20 (estimated)

## Conditions studied

- Post Cardiac Surgery Systemic Inflammatory Response

## Interventions

- **DRUG:** Alpha 1-Antitrypsin

## Key facts

- **NCT ID:** NCT02191839
- **Lead sponsor:** Soroka University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-07
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2014-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02191839

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02191839, "Single Dose Administration of Alpha-1 Anti-Trypsin for the Amelioration of Organ Injury in Patients Undergoing Cardiac Surgery". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT02191839. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*